Natalia Carmen Mendez, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 409 Kathleen Pl, Farmington, NM 87401 Phone: 505-917-5943 |
Meagan La Chance, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 E 20th St, Farmington, NM 87401 Phone: 505-325-1774 |
Bara Naam, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 E Main St, Farmington, NM 87402 Phone: 505-327-2036 |
Stacey Mclendon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-486-5264 |
C. Norman Finch Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 E Main St, Farmington, NM 87402 Phone: 505-327-0236 |
Jennifer Rae Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4221 E Main St, Farmington, NM 87402 Phone: 505-325-1749 |
Donna Doreen Walker, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 E Main St, Farmington, NM 87402 Phone: 505-326-1197 Fax: 505-325-9822 |
Dr. Rebecca Karen Schonemann, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1309 Griffin Ave Apt 6, Farmington, NM 87401 Phone: 505-675-5821 |
Jeffrey Allen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 E Main St, Farmington, NM 87402 Phone: 505-326-1197 |
Jaime Weiss, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 E 20th St, Farmington, NM 87401 Phone: 505-326-3342 |
Dr. Jeffery Scott Nygren Jr., PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4221 E Main St, Farmington, NM 87402 Phone: 505-325-1749 |
Dr. Claud Evans Dunlap Iii Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 E 20th St, Farmington, NM 87401 Phone: 505-326-3342 |
Percy E Collyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4221 E Main St, Farmington, NM 87402 Phone: 505-325-1749 Fax: 505-325-0262 |
Emily R Wegener, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1001 W Broadway Ste D, Farmington, NM 87401 Phone: 505-566-0623 Fax: 505-566-0323 |
Mr. Pablo Viramontes Iv, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4900 E Main St, T-0952, Farmington, NM 87402 Phone: 505-327-3555 |
Mary Hayashi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4500 E Main St, Farmington, NM 87402 Phone: 505-326-5384 Fax: 505-326-6920 |
Jacqueline Ball Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 E 20th St, Farmington, NM 87401 Phone: 505-325-1774 |
Michael Kekoa Andrews, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 E 20th St, Farmington, NM 87401 Phone: 505-325-1774 |
Devin Jack Signs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 E 20th St, Farmington, NM 87401 Phone: 505-326-3342 |
Bobby John Huffmyer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 E Main St, Farmington, NM 87402 Phone: 505-564-9195 |
News Archive
Aiming to increase the number of scientists from underrepresented minority groups conducting addiction research, the National Institute on Drug Abuse (NIDA) has awarded $1.5 million to support a new training program at The City College of New York.
Researchers at the RIKEN Center for Genomic Medicine (CGM), together with colleagues at Kyoto University, Tsukuba University, Harvard University, and other medical institutions have identified three new loci associated with susceptibility to adult asthma in the Japanese population.
A group of scientists in Princeton's Department of Ecology and Evolutionary Biology has uncovered a new biological mechanism that could provide a clearer window into a cell's inner workings.
Pomalidomide (trade name: Imnovid) has been approved since 2013 for the treatment of multiple myeloma that has returned and is difficult to treat. The drug is an option for adults who have received two or more prior treatment regimens, including treatment with the drugs lenalidomide and bortezomib, and in whom the last treatment had no sufficient effect.
› Verified 4 days ago